BTIG analyst Marie Thibault reiterated a Buy rating on Masimo (MASI – Research Report) today and set a price target of $178.00. The company’s ...

After its longtime chief was ousted last year following a proxy battle, Masimo has now appointed a new CEO. | The medtech has ...

Masimo (NASDAQ:MASI) is recognized for its innovative monitoring technologies, including measurements, sensors, patient ...

Masimo also said it continues to address its cost structure to improve gross margin performance. In November, the company said it would lay off 75 employees in Irvine, California, where it is based.

6 analysts have shared their evaluations of Masimo (NASDAQ:MASI) during the recent three months, expressing a mix of bullish and bearish perspectives. The table below provides a snapshot of their ...

IRVINE, Calif., January 16, 2025--Masimo Corporation (Nasdaq: MASI) today announced select preliminary financial results for the fourth quarter and full-year ended December 28, 2024 and provided ...

Needham reiterated its Hold rating on Masimo Corp. (NASDAQ:16565|MAMASI) shares, maintaining its stance on the stock without altering the price target. The decision comes after Masimo preannounced its ...

Wells Fargo analyst Vik Chopra added Masimo (MASI) to Q1 2025 “Tactical Ideas List.” The firm sees Masimo as well positioned for 2025 due to a potential separation of its Consumer business ...

IRVINE, Calif., November 26, 2024--Masimo (NASDAQ: MASI) today announced that its management will participate in the Piper Sandler 36th Annual Healthcare Conference on Tuesday, December 3 ...